However, whether these benefits are being mediated exclusively by targeting the CB1R needs further demonstration, as LH-21 was demonstrated to be able to activate another GPCR, the GPR55 receptor, in modulating islet hormone secretion and reverting obesity-induced anxiety (30, 36). The gene discussed is CNR1; the disease is obesity disorder.